We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Ionis Pharmaceuticals
IONS
$9.4B
| $4.25M | 0.01% |
139,749
+1,386
| +1% | +$43.6K |
|
1452
Rithm Capital
RITM
$5.69B
| $4.25M | 0.01% |
396,975
+8,469
| +2% | +$94.5K |
|
1453
National Vision
EYE
$1.81B
| $4.25M | 0.01% |
88,543
-472
| -0.5% | -$25.3K |
|
1454
MACOM Technology Solutions
MTSI
$23.7B
| $4.24M | 0.01% |
54,093
+225
| +0.4% | +$16.2K |
|
1455
BancFirst
BANF
$3.8B
| $4.23M | 0.01% |
59,909
-472
| -0.8% | -$31.2K |
|
1456
Supernus Pharmaceuticals
SUPN
$2.77B
| $4.22M | 0.01% |
144,853
-2,105
| -1% | -$63.9K |
|
|
BIG
1457
DELISTED
Big Lots, Inc.
BIG
| $4.21M | 0.01% |
93,540
-438
| -0.5% | -$19.9K |
|
1458
Deluxe
DLX
$1.15B
| $4.21M | 0.01% |
131,013
-272
| -0.2% | -$9.6K |
|
1459
DigitalOcean
DOCN
$14.6B
| $4.19M | 0.01% |
52,141
+1,336
| +3% | +$125K |
|
1460
Cannae Holdings
CNNE
$649M
| $4.19M | 0.01% |
119,129
-4,718
| -4% | -$156K |
|
1461
Northwest Natural Holdings
NWN
$2.12B
| $4.18M | 0.01% |
85,695
-239
| -0.3% | -$11.1K |
|
|
CDMO
1462
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $4.17M | 0.01% |
143,005
+77,823
| +119% | +$2.23M |
|
|
PRMW
1463
DELISTED
Primo Water Corporation
PRMW
| $4.17M | 0.01% |
236,317
-3,715
| -2% | -$63.8K |
|
1464
Agilon Health
AGL
$1.6B
| $4.16M | 0.01% |
6,156
+3,896
| +172% | +$2.37M |
|
1465
Chegg
CHGG
$102M
| $4.15M | 0.01% |
135,242
-3,004
| -2% | -$122K |
|
1466
PetMed Express
PETS
$42.3M
| $4.14M | 0.01% |
163,804
+4,055
| +3% | +$112K |
|
|
NVTA
1467
DELISTED
Invitae Corporation
NVTA
| $4.13M | 0.01% |
270,686
-213
| -0.1% | -$4.61K |
|
1468
Beam Therapeutics
BEAM
$2.84B
| $4.13M | 0.01% |
51,813
-128
| -0.2% | -$11K |
|
1469
Dave & Buster's
PLAY
$357M
| $4.12M | 0.01% |
107,395
-2,331
| -2% | -$86.4K |
|
1470
Carpenter Technology
CRS
$28.4B
| $4.12M | 0.01% |
141,116
-214
| -0.2% | -$6.67K |
|
1471
AAR Corp
AIR
$5.76B
| $4.11M | 0.01% |
105,232
-1,252
| -1% | -$44.7K |
|
1472
Sprout Social
SPT
$621M
| $4.11M | 0.01% |
45,280
-22
| -0% | -$2.49K |
|
1473
Upwork
UPWK
$1.19B
| $4.11M | 0.01% |
120,188
-1,252
| -1% | -$55.3K |
|
1474
RLJ Lodging Trust
RLJ
$1.69B
| $4.1M | 0.01% |
294,306
-2,613
| -0.9% | -$36.7K |
|
|
KRA
1475
DELISTED
Kraton Corporation
KRA
| $4.09M | 0.01% |
88,220
-976
| -1% | -$44.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.